Insight Genetics, St Jude Children’s Research Hospital Enter Licensing Agreement
Insight Genetics has licensed rights for mutations in the anaplastic lymphoma kinase (ALK) gene that confer resistance to ALK inhibitors.
Read More
Search Results for: lung cancer
Asuragen Receives Notice of Allowance from USPTO
Asuragen Inc has received a Notice of Allowance from the United States Patent and Trademark Office.
Read MoreInsight Genetics Awarded Phase I SBIR Contract
Insight Genetics has been awarded a $200,000 Phase I Small Business Innovation Research contract from the National Cancer Institute.
Read MorePresenters Discuss Oncimmune Blood Test at CHEST
Two oral presentations and five poster presentations during CHEST 2010 will collectively highlight the clinical and economic benefits of Oncimmune’s EarlyCDT-Lung.
Read MoreRPC, Provista Sign 5-Year Laboratory Services Agreement
Radient Pharmaceuticals Corporation has entered into an exclusive 5-year laboratory services agreement with Provista Diagnostics Inc.
Read More